Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Naunyn-Schmiedeberg'S Archives of Pharmacology|December 12, 2025
Data mining and experimental validation identify a core herb combination as a therapeutic agent for malignant lymphomaYidong Zhu, Ting Zhang, Xiaoyi JinCurrent Medicinal Chemistry|May 15, 2026
Identification and Experimental Validation of PLAC8 as a Biomarker for Follicular LymphomaTing Zhang, Li He, Yidong ZhuDiabetes, Obesity & Metabolism|October 7, 2024
Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathyYidong Zhu, Jun Liu, Bo WangJournal of Cellular and Molecular Medicine|June 26, 2024
Identification of biomarkers in multiple myeloma: A comprehensive study combining microarray analysis and Mendelian randomizationYidong Zhu, Jun Liu, Bo WangCurrent Medicinal Chemistry|July 2, 2025
Investigating the Biomarkers for Alzheimer's Disease: Insights from Microarray Analysis, Mendelian Randomization, and Experimental ValidationYidong Zhu, Xiaoyi Jin, Jun LiuCurrent Medicinal Chemistry|May 6, 2025
Identification and Validation of BATF3 as a Promising Biomarker Gene for Peripheral T-cell LymphomaYidong Zhu, Jun Liu, Ting ZhangCombinatorial Chemistry & High Throughput Screening|April 19, 2024
Integrated Bioinformatics and Experimental Validation to Identify a Disulfidptosis-Related lncRNA Model for Prognostic Prediction in Papillary Renal Cell CarcinomaYidong Zhu, Xiaoyi Jin, Jun LiuCurrent Gene Therapy|January 16, 2026
Identification and Experimental Validation of NOP10 as a Biomarker for Diffuse Large B-Cell LymphomaTing Zhang, Li He, Yidong ZhuDiabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 5, 2025
Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin LymphomaYidong Zhu, Jun Liu, Bo WangNaunyn-Schmiedeberg'S Archives of Pharmacology|January 14, 2026
Mechanism identification of an herbal decoction for potential treatment of diffuse large B-cell lymphoma using network pharmacology and experimental validationYidong Zhu, Ting Zhang, Fei WangPageof 5